Mon premier blog

Statistical Issues in Drug Development Stephen S Senn
Publisher: Wiley-Interscience

The last time I contacted NORD, they were unable able to provide me with any relevant statistics or facts on this drug development issue. Lynn Torbeck, Statistical Solutions Lynn D. - The statistics on drug development are no secret: for every 10000 compounds discovered, only one gets approved, and it usually takes 14 years and $1.2 billion to reach the market. This strategy is not as simple as it sounds, and issues, such as confidentiality and ownership, can be challenging. Against Counterfeit Drugs Continues. When handled properly, however, cross-company collaboration can result in a more efficient and profitable use of . Cancer experts say impending federal budget cuts known as sequestration will hurt the development of drugs and research for mesothelioma and other cancers. The author suggests co-opetition as a future model for collaboration in drug development. The Senate is strongly in favor of the proposal, but no bill has been proposed in the House. NCATS would "look at the pipeline itself as a scientific problem and be a more effective facilitator to resolve those problems," he said. Statistical Issues in Drug Development, 2nd edition by Stephen Senn English | 2008 | ISBN: 0470018771 | 524 pages | PDF | 4.50 MB. Analysis of the drug development enterprise invariably reveals a “pipeline” problem—a disconnection between the substantial resources invested in developing new therapies and the rate at which innovative therapeutic products reach patients.